For example, studies have shown that Orai3 is involved in various processes of breast cancer, such as proliferation and survival and resistance to chemotherapy, and the expressions of secretory pathway Ca2+-ATPases (SPCA1) and SPCA2 genes are significantly increased in breast cancer [104,105]. This evidence concerns the gene ORAI3 and breast carcinoma.